Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,967,700 | N/A | 15,938,490 | 2,350,350 | 1,850,660 |
| Receivables | 3,575,750 | N/A | 2,931,920 | 3,529,920 | 3,453,490 |
| Inventories | 2,009,610 | N/A | 1,613,310 | 2,565,160 | 2,474,600 |
| Other current assets | 142,270 | 83,860 | 34,280 | 412,030 | 571,650 |
| TOTAL | $8,695,330 | $83,860 | $20,518,000 | $8,857,460 | $8,350,400 |
| Non-Current Assets | |||||
| PPE Net | 4,844,840 | N/A | 3,019,650 | 4,203,240 | 4,274,210 |
| Investments And Advances | 244,050 | 295,730 | 194,630 | 222,340 | 374,860 |
| Other Non-Current Assets | 12,545,800 | 12,975,380 | 2,644,070 | 2,777,440 | 2,474,600 |
| TOTAL | $17,634,690 | $13,271,110 | $5,858,350 | $7,203,020 | $7,123,670 |
| Total Assets | $26,330,040 | $13,354,970 | $26,376,380 | $16,060,510 | $15,474,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,996,920 | 4,391,830 | 2,738,650 | 2,928,200 | 2,728,670 |
| Accrued Expenses | 707,060 | 772,430 | 381,050 | 0 | 0 |
| Other current liabilities | 1,111,490 | 1,243,240 | 710,020 | 748,690 | 1,028,700 |
| TOTAL | $6,351,000 | $8,376,090 | $6,070,830 | $4,595,170 | $4,675,230 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,864,360 | N/A | 2,678,340 | 3,204,560 | 3,365,070 |
| Other Non-Current Liabilities | 3,616,190 | 4,100,510 | 2,190,370 | 2,905,590 | 2,980,240 |
| TOTAL | $8,480,550 | $4,100,510 | $5,051,010 | $6,110,150 | $6,345,310 |
| Total Liabilities | $14,831,570 | $12,476,600 | $11,121,850 | $10,705,330 | $11,020,540 |
| Shareholders' Equity | |||||
| Common Shares | 648,480 | 681,210 | 719,610 | 721,050 | 712,360 |
| Retained earnings | 11,273,940 | N/A | 14,673,340 | 2,136,790 | 1,010,010 |
| Other shareholders' equity | -426,730 | -1,072,570 | -635,990 | 184,680 | 485,730 |
| TOTAL | $11,498,470 | $-391,360 | $15,254,520 | $5,355,180 | $4,453,550 |
| Total Liabilities And Equity | $26,330,040 | $12,085,240 | $26,376,370 | $16,060,510 | $15,474,090 |